Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea

References

• Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis 2001; 33: 806–814
   PubMed Web of Science ®Google Scholar
• Veasy L, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994; 124: 9–16
   PubMed Web of Science ®Google Scholar
• Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991; 10: 55–57
   PubMed Web of Science ®Google Scholar
• Antone SM, Adderson EE, Mertens NM, Cunningham MW. Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizs the heart cell surface protein laminin. J Immunol 1997; 159: 5422–5430
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470–511
   PubMed Web of Science ®Google Scholar
• Galvin JE, Hemric ME, Kosanke SD, Factor SM, Quinn A, Cunningham MW. Induction of myocarditis and valvulitis in lewis rats by different epitopes of cardiac Myosin and its implications in rheumatic carditis. Am J Pathol 2002; 160: 297–306
   PubMed Web of Science ®Google Scholar
• Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Investig 2000; 106: 217–224
   PubMed Web of Science ®Google Scholar
• Quinn A, Kosanke S, Fischetti VA, Factor SM, Cunningham MW. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun 2001; 69: 4072–4078
   PubMed Web of Science ®Google Scholar
• Roberts S, Kosanke S, Jankelow D, Duran CM, Cunningham MW. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J Infect Dis 2001; 183: 507–511
   PubMed Web of Science ®Google Scholar
• Marques-Dias MJ, Mercadante MT, Tucker D, Lombroso P. Sydenham's chorea. Psychiatr Clin North Am 1997; 20: 809–820
   Google Scholar
• Taranta A, Stollerman GH. The relationship of Sydenham's chorea to infection with group A streptococci. Am J Med 1956; 20: 170–175
   PubMed Web of Science ®Google Scholar
• Taranta A. Relation of isolated recurrences of Sydenham's chorea to preceding streptococcal infections. N Engl J Med 1959; 260: 1204–1210
   PubMed Web of Science ®Google Scholar
• Krisher K, Cunningham MW. Myosin: A link between streptococci and heart. Science 1985; 227: 413–415
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Swerlick RA. Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med 1986; 164: 998–1012
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Streptococcal sequelae and molecular mimicry. Effects of microbes on the immune system, MW Cunningham, RS Fujinami. Lippincott Williams and Wilkins, Philadelphia 2000
   Google Scholar
• Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143: 2677–2683
   PubMed Web of Science ®Google Scholar
• Shikhman AS, Greenspan NS, Cunningham MW. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M protein recognizes N-acetyl-β-d-glucosamine. J Immunol 1993; 151: 3902–3913
   PubMedGoogle Scholar
• Shikhman AR, Greenspan NS, Cunningham MW. Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-β-d-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response. J Immunol 1994; 153: 5593–5606
   PubMed Web of Science ®Google Scholar
• Shikhman AR, Cunningham MW. Immunological mimicry between N-acetyl-β-d-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J Immunol 1994; 152: 4375–4387
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Streptococci and rheumatic fever. Microorganisms and autoimmune disease. Platinum Press, New York 1996; 13
   Google Scholar
• Swedo SE, Leonard HL, Schapiro MB, Casey BJ, Mannheim GB, Lenane MC, Rettew DC. Sydenham's chorea: Physical and psychological symptoms of St Vitus dance. Pediatrics 1993; 91: 706–713
   PubMed Web of Science ®Google Scholar
• Giedd JN, Rapoport JL, Kruesi MJP, Parker C, Schapiro MB, Allen AJ, Leonard HL, Kaysen D, Dickstein DP, Marsh WL, Kozuch PL, Vaituzis AC, Hamburger SD, Swedo SE. Sydenham's chorea: Magentic resonance imaging of the basal ganglia. Neurology 1995; 45: 2199–2202
   PubMed Web of Science ®Google Scholar
• Bronze MS, Dale JB. Epitopes of Streptococcal M protein that evoke antibodies that cross-react with human brain. J Immunol 1993; 151: 2820–2828
   PubMed Web of Science ®Google Scholar
• Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams RC. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976; 144: 1094–1110
   PubMed Web of Science ®Google Scholar
• Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002; 59: 227–231
   PubMed Web of Science ®Google Scholar
• Snider LA, Swedo SE. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol 2003; 16: 359–365
   PubMed Web of Science ®Google Scholar
• Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH. Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 2003; 136: 154–161
   PubMedGoogle Scholar
• Morshed SA, Parveen S, Leckman JF, Mercadante MT, Bittencourt Kiss MH, Miguel EC, Arman A, Yazgan Y, Fujii T, Paul S, Peterson BS, Zhang H, King RA, Scahill L, Lombroso PJ. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 2001; 50: 566–577
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Hall NK, Krisher KK, Spanier AM. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol 1986; 136: 293–298
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Antone SM, Gulizia JM, McManus BA, Gauntt CJ. Alpha-helical coiled-coil molecules: A role in autoimmunity against the heart. Clin Immunol Immunopathol 1993; 68: 118–123
   Google Scholar
• Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol 1989; 142: 2475–2481
   PubMed Web of Science ®Google Scholar
• Adderson EE, Shikhman AR, Ward KE, Cunningham MW. Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: Human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol 1998; 161: 2020–2031
   PubMed Web of Science ®Google Scholar
• Coligan JE, Kindt TJ, Krause RM. Structure of the streptococcal groups A, A-variant and C carbohydrates. Immunochemistry 1978; 15: 755–760
   Google Scholar
• Greenspan NS, Monafo WJ, Davie JM. Interaction of IgG3 anti-streptococcal group A carbohydrate (GAC) antibody with streptococcal group A vaccine: Enhancing and inhibiting effects of anti-GAC, anti-isotypic, and anti-idiotypic antibodies. J Immunol 1987; 138: 285–292
   Google Scholar
• Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J Infect Dis 1995; 171: 593–600
   Web of Science ®Google Scholar
• McCarty M. Variation in the group-specific carbohydrate of group A streptococci. II. Studies on the chemical basis for serological specificity of the carbohydrates. J Exp Med 1956; 104: 629–643
   Google Scholar
• Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 472–511
   Google Scholar
• Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9: 914–920
   PubMed Web of Science ®Google Scholar
• Froude J, Gibofsky A, Buskirk DR, Khanna A, Zabriskie JB. Cross-reactivity between streptococcus and human tissue: A model of molecular mimicry and autoimmunity. Curr Top Microbiol Immunol 1989; 145: 5–26
   Google Scholar
• Dudding BA, Ayoub EM. Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med 1968; 128: 1081–1098
   PubMed Web of Science ®Google Scholar
• Goldstein I, Rebeyrotte P, Parlebas J, Halpern B. Isolation from heart valves of glycopeptides which share immunological properties with Streptococcus haemolyticus group A polysaccharides. Nature 1968; 219: 866–868
   Web of Science ®Google Scholar
• Malkiel S, Liao L, Cunningham MW, Diamond B. T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin. Infect Immun 2000; 68: 5803–5808
   PubMedGoogle Scholar
• Cunningham MW, Beeker A, Heuser JS, Hill H, Augustine N, Veesy G, Adderson EE. Insights into the immunology of acute rheumatic fever: A study of cytotoxicity and the TH1/TH2 paradigm.
   Google Scholar
• Hannun YA, Bell RM. Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidoses. Science 1987; 235(4789)670–674
   Google Scholar
• Kotani M, Tai T. An immunohistochemical technique with a series of monoclonal antibodies to gangliosides: Their differential distribution in the rat cerebellum. Brain Res Brain Res Protoc 1997; 1(2)152–156
   Google Scholar
• DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189–1193
   PubMed Web of Science ®Google Scholar
• Quattrini A, Lorenzetti I, Sciorati C, Corbo M, Previtali SC, Feltri ML, Canal N, Wrabetz L, Nemni R, Clementi E. Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells. J Neuroimmunol 2001; 114: 213–219
   Google Scholar
• Kasahara K, Watanabe K, Takeuchi K, Kaneko H, Oohira A, Yamamoto T, Sanai Y. Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts. J Biol Chem 2000; 275: 34701–34709
   PubMed Web of Science ®Google Scholar
• Chen C, Rainnie DG, Greene RW, Tonegawa S. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science 1994; 266: 291–294
   PubMed Web of Science ®Google Scholar
• Schulman H, Heist K, Srinivasan M. Decoding Ca2+ signals to the nucleus by multifunctional CaM kinase. Prog Brain Res 1995; 105: 95–104
   Google Scholar
• Silva AJ, Stevens CF, Tonegawa S, Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 1992; 257: 201–206
   PubMed Web of Science ®Google Scholar
• Zhao W, Lawen A, Ng KT. Changes in phosphorylation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) in processing of short-term and long-term memories after passive avoidance learning. J Neurosci Res 1999; 55: 557–568
   Google Scholar
• Moran AP, Annuk H, Prendergast MM. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J Neuroimmunol 2005; 165: 179–185
   Google Scholar
• Paparounas K, O'Hanlon GM, O'Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 1999; 122: 807–816
   PubMed Web of Science ®Google Scholar
• O'Hanlon GM, Plomp JJ, Chakrabarti M, Morrison I, Wagner ER, Goodyear CS, Yin X, Trapp BDT, Conner J, Molenarr PC, Stewart S, Rowan EG, Willison HJ. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nreve terminal. Brain 2001; 124: 893–906
   PubMed Web of Science ®Google Scholar
• Zhang G, Lopez PH, Li CY, Mehta NR, Griffin JW, Schnaar RL, Sheikh KA. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: Implications for immune neuropathies. Brain 2004; 127: 1085–1100
   PubMed Web of Science ®Google Scholar
• Traill Z, Pike M, Byrne J. Sydenham's chorea: A case showing reversible striatal abnormalities on CT and MRI. Dev Med Child Neurol 1995; 37: 270–273
   Google Scholar
• Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 2005; 20: 424–429
   PubMed Web of Science ®Google Scholar
• Kantor L, Hewlett GH, Gnegy ME. Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: Differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J Neurosci 1999; 19: 3801–3808
   Google Scholar
• Chi P, Greengard P, Ryan TA. Synapsin dispersion and reclustering during synaptic activity. Nat Neurosci 2001; 4: 1187–1193
   Google Scholar
• Consogno E, Tiraboschi E, Iuliano E, Gennarelli M, Racagni G, Popoli M. Long-term treatment with S-adenosylmethionine induces changes in presynaptic CaM kinase II and synapsin I. Biol Psychiatry 2001; 50: 337–344
   Google Scholar
• Iwata SI, Hewlett GH, Ferrell ST, Kantor L, Gnegy ME. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine. J Pharmacol Exp Ther 1997; 283: 1445–1452
   Google Scholar
• Sutoo D, Akiyama K. Neurochemical changes in mice following physical or psychological stress exposures. Behav Brain Res 2002; 134: 347–354
   Google Scholar
• Bevilaqua LR, Graham ME, Dunkley PR, von Nagy-Felsobuki EI, Dickson PW. Phosphorylation of Ser(19) alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of Ser(40). J Biol Chem 2001; 276: 40411–40416
   Google Scholar
• Nausieda PA, Bieliauskas LA, Bacon LD, Hagerty M, Koller WC, Glantz RN. Chronic dopaminergic sensitivity after Sydenham's chorea. Neurology 1983; 33: 750–754
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994; 93: 323–326
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264–271
   PubMed Web of Science ®Google Scholar
• Swedo SE. Sydenham's chorea: A model of childhood autoimmune neuropsychiatric disorders. JAMA 1994; 272: 1788–1791
   PubMed Web of Science ®Google Scholar
• Garvey MA, Giedd J, Swedo SE. PANDAS: The search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol 1998; 13: 413–423
   PubMed Web of Science ®Google Scholar
• Leonard HL, Swedo SE. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol 2001; 4: 191–198
   PubMed Web of Science ®Google Scholar
• Murphy TK, Goodman WK, Ayoub EM, Voeller KK. On defining Sydenham's chorea: Where do we draw the line?. Biol Psychiatry 2000; 47: 851–857
   Google Scholar
• Kirvan CA, et al. Antibody-mediated neuronal cell signaling links pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) with Sydenham's chorea, submitted.
   Google Scholar